AbbVie
ABBV
ABBV
1,296 hedge funds and large institutions have $49B invested in AbbVie in 2013 Q3 according to their latest regulatory filings, with 76 funds opening new positions, 477 increasing their positions, 562 reducing their positions, and 53 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
0.88% more ownership
Funds ownership: 68.14% → 69.02% (+0.88%)
1% more funds holding
Funds holding: 1,286 → 1,296 (+10)
15% less repeat investments, than reductions
Existing positions increased: 477 | Existing positions reduced: 562
Holders
1,296
Holding in Top 10
42
Calls
$297M
Puts
$111M
Top Buyers
| 1 | +$136M | |
| 2 | +$118M | |
| 3 | +$112M | |
| 4 |
JHIU
Janus Henderson Investors US
Denver,
Colorado
|
+$104M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$94M |
Top Sellers
| 1 | -$125M | |
| 2 | -$70.9M | |
| 3 | -$67M | |
| 4 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
-$60.6M |
| 5 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$51.4M |